U.S. federal trademark · Serial No. 98688540 · Reg. No. 019064791
Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; therapeutic pharmaceuticals, namely, antibody-drug conjugates for the treatment of cancer; pharmaceutical and veterinary preparations comprising small molecules for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases and liver metabolic disorders; small molecule compounds being pharmaceuticals for the for treatment of cancer
Scientific and technological services, namely, scientific research, analysis, testing and design in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry and in the discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and/or diagnostic apparatus
Chemical, biochemical, biological, and biotechnological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodies, fragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.